Recnac Oncology Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 94.75%
- Profit Growth 321.58%
- Ebitda 480.08%
- Net Worth 62.15%
- Total Assets 111.61%
About Recnac Oncology
Recnac Oncology Private Limited (ROPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 November 2018 (Six years and five months 21 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Dhanasekar Padmanabhan, Duraisamy Sriprakash, Ramani Balaji, and Two other members serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U93000TN2018PTC125864
- Company No.
125864
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Nov 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Healthcare
Recnac Oncology Private Limited
Explore comprehensive data for Recnac Oncology Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Recnac Oncology?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Duraisamy Sriprakash  | Managing Director | 19-Nov-2018 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ganesamoni Sivaram | Additional Director | 23-Nov-2018 | Current |
| Ramani Balaji | Director | 19-Nov-2018 | Current |
| Dhanasekar Padmanabhan | Director | 19-Nov-2018 | Current |
| Mahalingam Sivakumar | Additional Director | 23-Nov-2018 | Current |
Financial Performance of Recnac Oncology.
Recnac Oncology Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 94.75% increase. The company also saw a substantial improvement in profitability, with a 321.58% increase in profit. The company's net worth Soared by an impressive increase of 62.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Recnac Oncology?
In 2021, Recnac Oncology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bavida Ventures LlpDhanasekar Padmanabhan is a mutual person
- Vinayaggas Infratech Private Limited
Ganesamoni Sivaram is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Recnac Oncology?
Unlock and access historical data on people associated with Recnac Oncology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Recnac Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Recnac Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Recnac Oncology
Recent activity within the organization
- Annual General Meeting
Recnac Oncology Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Recnac Oncology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
- Director Appointment
Mahalingam Sivakumar was appointed as a Additional Director was appointed as a Additional Director on 23 Nov 2018 & has been associated with this company since 6 years 5 months .
- Director Appointment
Ganesamoni Sivaram was appointed as a Additional Director was appointed as a Additional Director on 23 Nov 2018 & has been associated with this company since 6 years 5 months .
- Director Appointment
Dhanasekar Padmanabhan was appointed as a Director was appointed as a Director on 19 Nov 2018 & has been associated with this company since 6 years 5 months .
- Director Appointment
Duraisamy Sriprakash was appointed as a Managing Director was appointed as a Managing Director on 19 Nov 2018 & has been associated with this company since 6 years 5 months .
Frequently asked questions
What is the Incorporation or founding date of Recnac Oncology Private Limited?
Recnac Oncology Private Limited was incorporated on 19 Nov 2018.
What is authorized share capital and paid-up capital of Recnac Oncology Private Limited?
The authorized share capital of Recnac Oncology Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.50 M.
Who are the current board members & directors of Recnac Oncology Private Limited?
Currently 5 directors are associated with Recnac Oncology Private Limited.
- Dhanasekar Padmanabhan
- Duraisamy Sriprakash
- Ramani Balaji
- Mahalingam Sivakumar
- Ganesamoni Sivaram
What is the registered address of Recnac Oncology Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Recnac Oncology Private Limited is No.11 Gopalakrishnan Street Tnagar India, Chennai, Tamil Nadu, 600017.
What is the corporate identification number (CIN) and company number of Recnac Oncology Private Limited?
The corporate identification number (CIN) of Recnac Oncology Private Limited is U93000TN2018PTC125864 and the company number is 125864 as per Ministry of Corporate Affairs (MCA).
What is the official website of Recnac Oncology Private Limited?
The Official website of Recnac Oncology Private Limited is https://www.recnaconcology.com
What has been the recent revenue trend for Recnac Oncology Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Recnac Oncology Private Limited has risen by 94.75%.
What change has been observed in the net worth of Recnac Oncology Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Recnac Oncology Private Limited has experienced an upsurge of 62.15%.
When was the last Balance Sheet of Recnac Oncology Private Limited filed with the ROC?
The most recent Balance Sheet for Recnac Oncology Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records